HOPMAN MARK (Chief Commercial Officer) sold 4.1% of their position (5.33K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $101.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0002048497-26-000012
Officer· Chief Commercial Officer
Since Mar 2026
-5.33K
Net shares
Net seller
$101.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.33K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.33K
Price / share
$19.11
Trade value
$101.82K
% of position
4.1%
9/2/2026
129.35K→124.03K
Total
Net shares
−5.33K
Net value
-$101.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −5.33K | $19.11 | $101.82K | 4.1% | 129.35K | 124.03K |
| Total | −5.33K | -$101.82K | ||||||
Derivative Transactions0
No derivative transactions reported